These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10601262)

  • 1. The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation.
    Sayas CL; Moreno-Flores MT; Avila J; Wandosell F
    J Biol Chem; 1999 Dec; 274(52):37046-52. PubMed ID: 10601262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3 is activated in neuronal cells by Galpha12 and Galpha13 by Rho-independent and Rho-dependent mechanisms.
    Sayas CL; Avila J; Wandosell F
    J Neurosci; 2002 Aug; 22(16):6863-75. PubMed ID: 12177184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.
    Sun Y; Kim NH; Yang H; Kim SH; Huh SO
    Mol Cells; 2011 May; 31(5):483-9. PubMed ID: 21499833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3.
    Sayas CL; Avila J; Wandosell F
    Biochim Biophys Acta; 2002 May; 1582(1-3):144-53. PubMed ID: 12069822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction.
    Sayas CL; Ariaens A; Ponsioen B; Moolenaar WH
    Mol Biol Cell; 2006 Apr; 17(4):1834-44. PubMed ID: 16452634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction.
    Kranenburg O; Poland M; van Horck FP; Drechsel D; Hall A; Moolenaar WH
    Mol Biol Cell; 1999 Jun; 10(6):1851-7. PubMed ID: 10359601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
    Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of glycogen synthase kinase-3beta (GSK-3beta) protein expression during neuroblastoma IMR-32 cell differentiation.
    Muñoz-Montaño JR; Moreno FJ; Avila J; Díaz-Nido J
    J Neurosci Res; 1999 Feb; 55(3):278-85. PubMed ID: 10348658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperosmotic stress-induced apoptosis and tau phosphorylation in human neuroblastoma cells.
    Stoothoff WH; Johnson GV
    J Neurosci Res; 2001 Sep; 65(6):573-82. PubMed ID: 11550225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid-induced neurite retraction in PC12 cells: control by phosphoinositide-Ca2+ signaling and Rho.
    Tigyi G; Fischer DJ; Sebök A; Yang C; Dyer DL; Miledi R
    J Neurochem; 1996 Feb; 66(2):537-48. PubMed ID: 8592123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
    Ishii T; Furuoka H; Muroi Y; Nishimura M
    J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
    Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
    J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
    Hanger DP; Hughes K; Woodgett JR; Brion JP; Anderton BH
    Neurosci Lett; 1992 Nov; 147(1):58-62. PubMed ID: 1336152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
    Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of phosphatidylinositol-3-kinase induces neurite retraction and activates GSK3.
    Sanchez S; Sayas CL; Lim F; Diaz-Nido J; Avila J; Wandosell F
    J Neurochem; 2001 Aug; 78(3):468-81. PubMed ID: 11483649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
    Hernández M; Barrero MJ; Crespo MS; Nieto ML
    J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized phosphorylation of vimentin by rho-kinase in neuroblastoma N2a cells.
    Nakamura Y; Hashimoto R; Amano M; Nagata K; Matsumoto N; Goto H; Fukusho E; Mori H; Kashiwagi Y; Kudo T; Inagaki M; Takeda M
    Genes Cells; 2000 Oct; 5(10):823-37. PubMed ID: 11029658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M; Yasutake K; Tomizawa K
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.
    Maldonado H; Ramírez E; Utreras E; Pando ME; Kettlun AM; Chiong M; Kulkarni AB; Collados L; Puente J; Cartier L; Valenzuela MA
    J Neurosci Res; 2011 Sep; 89(9):1489-98. PubMed ID: 21671254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary tangles and tau phosphorylation.
    Brion JP; Anderton BH; Authelet M; Dayanandan R; Leroy K; Lovestone S; Octave JN; Pradier L; Touchet N; Tremp G
    Biochem Soc Symp; 2001; (67):81-8. PubMed ID: 11447842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.